Medicaid expansion and medications to treat opioid use disorder in outpatient specialty care from 2010 to 2020.

ABSTRACT:

Introduction

Medications for opioid use disorder (MOUD) are considered the first line treatment for opioid use disorder. As states expanded Medicaid beginning in 2014 under the Affordable Care Act, policymakers and public health officials were interested in the potential for expansion to increase access to MOUD. This study examined whether there were changes in MOUD use within outpatient admissions to specialty treatment facilities in Medicaid expansion states beyond the initial expansion period.

Methods

Analyses were conducted using 2010-2020 data from the Treatment Episode Data Set - Admissions. For states that expanded Medicaid prior to 2015, a difference-in-differences analysis was conducted to evaluate whether expansion was associated with an increased proportion of MOU

SUBMITTER: Presskreischer R 

PROVIDER: S-EPMC11624050 | biostudies-literature | 2025 Jan

REPOSITORIES: biostudies-literature